furosemide has been researched along with Canine Diseases in 63 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To test the long-term effect of enalapril maleate treatment on progression of clinical signs of heart disease in dogs with moderate or severe naturally acquired heart failure associated with chronic degenerative mitral valvular disease (mitral regurgitation [MR]) or dilated cardiomyopathy (DCM)." | 9.08 | Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group. ( Benitz, AM; Cifelli, S; Ericsson, GF; Ettinger, SJ; Hanson, PD; Jernigan, AD; Longhofer, SL; Trimboli, W, 1998) |
| " It can cause sterile hemorrhagic cystitis (SHC), and furosemide is used to decrease the incidence of SHC." | 8.12 | Incidence of Sterile Hemorrhagic Cystitis in Dogs Treated with Cyclophosphamide and Low-Dose Furosemide. ( Gagnon, J; Iwaki, Y; MacDonald-Dickinson, V, 2022) |
| "Kidney injury (KI) has been documented in dogs treated with furosemide for left-sided congestive heart failure (CHF)." | 8.12 | Retrospective evaluation of risk factors for development of kidney injury after parenteral furosemide treatment of left-sided congestive heart failure in dogs. ( Adin, DB; Giorgi, ME; Mochel, JP; Ward, JL; Yuan, L, 2022) |
| "The aim of this study was to determine whether the addition of constant rate infusion (CRI) to intermittent intravenous bolus (IVB) administration of furosemide resulted in an improvement in medical outcomes in dogs and cats with acute left-sided congestive heart failure (L-CHF)." | 7.88 | Constant rate infusion vs. intermittent bolus administration of IV furosemide in 100 pets with acute left-sided congestive heart failure: A retrospective study. ( Aroch, I; Bdolah-Abram, T; Kelmer, E; Klainbart, S; Ohad, DG; Segev, G; Segev, Y, 2018) |
| " The aim of the present study was to compare the efficacy of mesna versus diuresis with furosemide in preventing SHC in dogs treated with cyclophosphamide within a multidrug chemotherapy induction protocol for malignant lymphoma." | 7.80 | Mesna and furosemide for prevention of cyclophosphamide-induced sterile haemorrhagic cystitis in dogs--a retrospective study. ( Hirschberger, J; Laberke, S; Zenker, I, 2014) |
| "To evaluate the incidence of sterile hemorrhagic cystitis (SHC) and other adverse effects in dogs following oral administration of the single-day, maximum-tolerated dose (MTD) of cyclophosphamide divided over 3 days as part of a multiagent chemotherapy protocol for treatment of lymphoma without concurrent administration of furosemide." | 7.79 | Incidence of sterile hemorrhagic cystitis in dogs receiving cyclophosphamide orally for three days without concurrent furosemide as part of a chemotherapeutic treatment for lymphoma: 57 cases (2007-2012). ( Best, MP; Fry, DR, 2013) |
| "To determine incidence and identify predisposing factors for sterile hemorrhagic cystitis (SHC) in dogs with lymphoma that were treated with cyclophosphamide and to evaluate whether furosemide administered i." | 7.72 | Risk factors for sterile hemorrhagic cystitis in dogs with lymphoma receiving cyclophosphamide with or without concurrent administration of furosemide: 216 cases (1990-1996). ( Bergman, PJ; Charney, SC; Hohenhaus, AE; McKnight, JA, 2003) |
| "Mean furosemide dose on day 0 was 5." | 6.77 | Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease. ( Machen, MC; Oyama, MA; Peddle, GD; Reynolds, CA; Singletary, GE; Trafny, DJ, 2012) |
| "Eight healthy dogs, 6 dogs with congestive heart failure (CHF)." | 5.56 | Prediction and measurement of diuretic responsiveness after oral administration of furosemide to healthy dogs and dogs with congestive heart failure. ( Huh, T; Larouche-Lebel, É; Loughran, KA; Oyama, MA; Rao, VS; Testani, JM, 2020) |
| " Diuresis using furosemide is effective in canines when maximally tolerated dosed cyclophosphamide is administered." | 5.46 | Furosemide for prevention of cyclophosphamide-associated sterile haemorrhagic cystitis in dogs receiving metronomic low-dose oral cyclophosphamide. ( Bunn, T; Ma, M; Setyo, L; Wang, P; Wyatt, K, 2017) |
| "Diuretics, such as furosemide, are routinely administered to dogs with congestive heart failure (CHF)." | 5.41 | Toward quantification of loop diuretic responsiveness for congestive heart failure. ( Adin, D; Oyama, MA, 2023) |
| "Triple therapy (TT) consisting of furosemide, pimobendan, and an angiotensin-converting enzyme inhibitor (ACEI) frequently is recommended for the treatment of congestive heart failure (CHF) attributable to myxomatous mitral valve disease (MMVD)." | 5.34 | Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial. ( Bauer, A; Gaugele, J; Glaus, T; Holler, P; Keller, L; Killich, M; Kresken, JG; Küchenhof, H; Simak, J; Wendt, R; Wess, G, 2020) |
| "To test the long-term effect of enalapril maleate treatment on progression of clinical signs of heart disease in dogs with moderate or severe naturally acquired heart failure associated with chronic degenerative mitral valvular disease (mitral regurgitation [MR]) or dilated cardiomyopathy (DCM)." | 5.08 | Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group. ( Benitz, AM; Cifelli, S; Ericsson, GF; Ettinger, SJ; Hanson, PD; Jernigan, AD; Longhofer, SL; Trimboli, W, 1998) |
| " Furosemide was administered intravenously at 2-4 mg/kg every 1-2 hours until completion of the dehydration model." | 4.31 | Plasma N-terminal pro-atrial natriuretic peptide concentrations are affected by dehydration in healthy dogs. ( Hsu, HH; Ishizaka, M; Kojima, Y; Miyagawa, Y; Miyakawa, H; Ogawa, M; Takemura, N, 2023) |
| "Furosemide is a mainstay of treatment in congestive heart failure (CHF) and is widely prescribed to dogs and cats by several formulations, including the subcutaneous one." | 4.31 | Dermatologic adverse effect of subcutaneous furosemide administration in a cat. ( Aspidi, F; Mazzoldi, C; Romito, G, 2023) |
| " It can cause sterile hemorrhagic cystitis (SHC), and furosemide is used to decrease the incidence of SHC." | 4.12 | Incidence of Sterile Hemorrhagic Cystitis in Dogs Treated with Cyclophosphamide and Low-Dose Furosemide. ( Gagnon, J; Iwaki, Y; MacDonald-Dickinson, V, 2022) |
| "Kidney injury (KI) has been documented in dogs treated with furosemide for left-sided congestive heart failure (CHF)." | 4.12 | Retrospective evaluation of risk factors for development of kidney injury after parenteral furosemide treatment of left-sided congestive heart failure in dogs. ( Adin, DB; Giorgi, ME; Mochel, JP; Ward, JL; Yuan, L, 2022) |
| "At the diagnosis of advanced heart failure, doses of pimobendan (n = 30), furosemide (n = 28), ACEI (n = 13), and spironolactone (n = 4) were increased, with ≥1 new medications added in most dogs." | 3.88 | Clinical findings and survival time in dogs with advanced heart failure. ( Beaumier, A; Freeman, LM; Rush, JE; Yang, VK, 2018) |
| "The aim of this study was to determine whether the addition of constant rate infusion (CRI) to intermittent intravenous bolus (IVB) administration of furosemide resulted in an improvement in medical outcomes in dogs and cats with acute left-sided congestive heart failure (L-CHF)." | 3.88 | Constant rate infusion vs. intermittent bolus administration of IV furosemide in 100 pets with acute left-sided congestive heart failure: A retrospective study. ( Aroch, I; Bdolah-Abram, T; Kelmer, E; Klainbart, S; Ohad, DG; Segev, G; Segev, Y, 2018) |
| " The aim of the present study was to compare the efficacy of mesna versus diuresis with furosemide in preventing SHC in dogs treated with cyclophosphamide within a multidrug chemotherapy induction protocol for malignant lymphoma." | 3.80 | Mesna and furosemide for prevention of cyclophosphamide-induced sterile haemorrhagic cystitis in dogs--a retrospective study. ( Hirschberger, J; Laberke, S; Zenker, I, 2014) |
| "To evaluate the incidence of sterile hemorrhagic cystitis (SHC) and other adverse effects in dogs following oral administration of the single-day, maximum-tolerated dose (MTD) of cyclophosphamide divided over 3 days as part of a multiagent chemotherapy protocol for treatment of lymphoma without concurrent administration of furosemide." | 3.79 | Incidence of sterile hemorrhagic cystitis in dogs receiving cyclophosphamide orally for three days without concurrent furosemide as part of a chemotherapeutic treatment for lymphoma: 57 cases (2007-2012). ( Best, MP; Fry, DR, 2013) |
| "This retrospective study reports the survival time [onset of congestive heart failure (CHF) to death from any cause] of 21 dogs with mitral regurgitation (MR) and CHF treated with a combination of furosemide, angiotensin-converting enzyme inhibitor (ACEI, benazepril, or enalapril), pimobendan, spironolactone, and amlodipine." | 3.77 | Survival and echocardiographic data in dogs with congestive heart failure caused by mitral valve disease and treated by multiple drugs: a retrospective study of 21 cases. ( de Madron, E; King, JN; Strehlau, G; White, RV, 2011) |
| "To determine incidence and identify predisposing factors for sterile hemorrhagic cystitis (SHC) in dogs with lymphoma that were treated with cyclophosphamide and to evaluate whether furosemide administered i." | 3.72 | Risk factors for sterile hemorrhagic cystitis in dogs with lymphoma receiving cyclophosphamide with or without concurrent administration of furosemide: 216 cases (1990-1996). ( Bergman, PJ; Charney, SC; Hohenhaus, AE; McKnight, JA, 2003) |
| " Furosemide was chosen because of its wide use in the management of heart failure in dogs." | 3.69 | Prolonged-release hard gelatin capsules of furosemide for the treatment of dogs. ( Haapala, O; Happonen, I; Kuusela, S; Marvola, M; Smal, J, 1995) |
| "Four dogs with congestive heart failure associated with dirofilariasis and mitral valvular incompetence initially responded to treatment with digoxin or etamiphylline camsylate, and frusemide but became refractory to this therapy and were in cardiac decompensation." | 3.66 | The use of alpha blockade in the treatment of congestive heart failure associated with dirofilariasis and mitral valvular incompetence. ( Atwell, RB, 1979) |
| "Mean furosemide dose on day 0 was 5." | 2.77 | Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease. ( Machen, MC; Oyama, MA; Peddle, GD; Reynolds, CA; Singletary, GE; Trafny, DJ, 2012) |
| "While rare, improvement in mitral regurgitation severity may occur without surgical intervention, allowing for reverse left-sided cardiac remodeling and discontinuation of furosemide." | 1.91 | Resolution of congestive heart failure and reverse remodeling in two Chihuahuas with flail mitral valve leaflets. ( Wesselowski, S, 2023) |
| "cardiac death or death for other causes)." | 1.62 | Multiple retrospective analysis of survival and evaluation of cardiac death predictors in a population of dogs affected by degenerative mitral valve disease in ACVIM class C treated with different therapeutic protocols. ( Bagardi, M; Brambilla, PG; Galizzi, A; Locatelli, C; Malchiodi, D; Zanaboni, A, 2021) |
| "Eight healthy dogs, 6 dogs with congestive heart failure (CHF)." | 1.56 | Prediction and measurement of diuretic responsiveness after oral administration of furosemide to healthy dogs and dogs with congestive heart failure. ( Huh, T; Larouche-Lebel, É; Loughran, KA; Oyama, MA; Rao, VS; Testani, JM, 2020) |
| " Diuresis using furosemide is effective in canines when maximally tolerated dosed cyclophosphamide is administered." | 1.46 | Furosemide for prevention of cyclophosphamide-associated sterile haemorrhagic cystitis in dogs receiving metronomic low-dose oral cyclophosphamide. ( Bunn, T; Ma, M; Setyo, L; Wang, P; Wyatt, K, 2017) |
| "In humans with congestive heart failure (CHF), better outcome is correlated with lower natriuretic peptide (NP) levels after starting treatment and greater percentage reduction of NP levels." | 1.38 | Lowered N-terminal pro-B-type natriuretic peptide levels in response to treatment predict survival in dogs with symptomatic mitral valve disease. ( Gerlach, N; Klima, A; Weber, K; Wess, G; Wolf, J, 2012) |
| "Chiari malformations and syringomyelia were not improved because of congenital disorders." | 1.35 | Syringomyelia in three small breed dogs secondary to Chiari-like malformation: clinical and diagnostic findings. ( Kang, BT; Park, C; Park, HM; Yoo, JH, 2009) |
| "Perimembranous ventricular septal defect is a common congenital heart disease in the dog." | 1.34 | Aortic endocarditis associated with a perforated septal membranous aneurysm in a boxer dog. ( Buratti, E; Mavropoulou, A; Quintavalla, C, 2007) |
| "22 dogs with clinical signs of congestive heart failure (CHF) attributable to mitral regurgitation." | 1.29 | Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation. ( Häggström, J; Hansson, K; Karlberg, BE; Kvart, C; Madej, A; Olsson, K, 1996) |
| "Propranolol was preferred to diltiazem for treating feline hypertrophic cardiomyopathy." | 1.29 | Preferences of veterinarians for drugs to treat heart disease in dogs and cats. ( Church, DB; Watson, AD, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (19.05) | 18.7374 |
| 1990's | 9 (14.29) | 18.2507 |
| 2000's | 9 (14.29) | 29.6817 |
| 2010's | 18 (28.57) | 24.3611 |
| 2020's | 15 (23.81) | 2.80 |
| Authors | Studies |
|---|---|
| Bagardi, M | 3 |
| Palermo, V | 1 |
| Locatelli, C | 3 |
| Colombo, FM | 1 |
| Pazzagli, L | 1 |
| Brambilla, PG | 3 |
| Iwaki, Y | 1 |
| Gagnon, J | 1 |
| MacDonald-Dickinson, V | 1 |
| Sabetti, MC | 1 |
| Fidanzio, F | 1 |
| Troìa, R | 1 |
| Perissinotto, L | 1 |
| Romito, G | 2 |
| Mazzoldi, C | 2 |
| Quintavalla, C | 2 |
| Crosara, S | 1 |
| Dondi, F | 1 |
| Giorgi, ME | 1 |
| Mochel, JP | 1 |
| Yuan, L | 1 |
| Adin, DB | 1 |
| Ward, JL | 1 |
| Oyama, MA | 7 |
| Adin, D | 3 |
| Wesselowski, S | 1 |
| Ogawa, M | 1 |
| Kojima, Y | 1 |
| Ishizaka, M | 1 |
| Miyakawa, H | 1 |
| Hsu, HH | 1 |
| Miyagawa, Y | 1 |
| Takemura, N | 1 |
| Aspidi, F | 1 |
| Pirintr, P | 1 |
| Saengklub, N | 1 |
| Boonpala, P | 1 |
| Hamlin, RL | 3 |
| Kijtawornrat, A | 1 |
| Besche, B | 1 |
| Blondel, T | 1 |
| Guillot, E | 1 |
| Garelli-Paar, C | 1 |
| Wess, G | 2 |
| Kresken, JG | 1 |
| Wendt, R | 1 |
| Gaugele, J | 1 |
| Killich, M | 1 |
| Keller, L | 1 |
| Simak, J | 1 |
| Holler, P | 1 |
| Bauer, A | 1 |
| Küchenhof, H | 1 |
| Glaus, T | 1 |
| Loughran, KA | 1 |
| Larouche-Lebel, É | 1 |
| Huh, T | 1 |
| Testani, JM | 1 |
| Rao, VS | 1 |
| Galizzi, A | 2 |
| Stranieri, A | 1 |
| Zanaboni, AM | 1 |
| Malchiodi, D | 2 |
| Borromeo, V | 1 |
| Zanaboni, A | 1 |
| Roche-Catholy, M | 1 |
| Van Cappellen, I | 1 |
| Locquet, L | 1 |
| Broeckx, BJG | 1 |
| Paepe, D | 1 |
| Smets, P | 1 |
| Ames, MK | 1 |
| Atkins, CE | 1 |
| Eriksson, A | 1 |
| Hess, AM | 1 |
| Beaumier, A | 1 |
| Rush, JE | 2 |
| Yang, VK | 1 |
| Freeman, LM | 2 |
| Ohad, DG | 1 |
| Segev, Y | 1 |
| Kelmer, E | 1 |
| Aroch, I | 1 |
| Bdolah-Abram, T | 1 |
| Segev, G | 1 |
| Klainbart, S | 1 |
| Yata, M | 1 |
| Kooistra, HS | 1 |
| Beijerink, NJ | 1 |
| Schmid, SM | 1 |
| Cianciolo, RE | 1 |
| Drobatz, KJ | 1 |
| Sanchez, M | 1 |
| Price, JM | 1 |
| King, LG | 1 |
| Best, MP | 1 |
| Fry, DR | 1 |
| Laberke, S | 1 |
| Zenker, I | 1 |
| Hirschberger, J | 1 |
| Setyo, L | 1 |
| Ma, M | 1 |
| Bunn, T | 1 |
| Wyatt, K | 1 |
| Wang, P | 1 |
| Russell, NJ | 1 |
| Irwin, PJ | 1 |
| Hopper, BJ | 1 |
| Olivry, T | 1 |
| Nicholls, PK | 1 |
| Chanoit, G | 1 |
| Bublot, I | 1 |
| Viguier, E | 1 |
| Park, C | 1 |
| Kang, BT | 1 |
| Yoo, JH | 1 |
| Park, HM | 1 |
| Goutal, CM | 1 |
| Keir, I | 1 |
| Kenney, S | 1 |
| Martin, MW | 1 |
| Stafford Johnson, MJ | 1 |
| Strehlau, G | 2 |
| King, JN | 2 |
| Peddle, GD | 2 |
| Reynolds, CA | 2 |
| Singletary, GE | 2 |
| Boissevain, I | 1 |
| Stosic, A | 1 |
| Ondreka, N | 1 |
| Henrich, E | 1 |
| Hassdenteufel, E | 1 |
| Schneider, M | 1 |
| Trafny, DJ | 1 |
| Machen, MC | 1 |
| de Madron, E | 1 |
| White, RV | 1 |
| Wolf, J | 1 |
| Gerlach, N | 1 |
| Weber, K | 1 |
| Klima, A | 1 |
| Caivano, D | 1 |
| Birettoni, F | 1 |
| Fruganti, A | 1 |
| Rishniw, M | 1 |
| Knafelz, P | 1 |
| Moïse, NS | 1 |
| Porciello, F | 1 |
| Charney, SC | 1 |
| Bergman, PJ | 1 |
| Hohenhaus, AE | 1 |
| McKnight, JA | 1 |
| Tidholm, A | 1 |
| Falk, T | 1 |
| Gundler, S | 1 |
| Svensson, H | 1 |
| Ablad, B | 1 |
| Sylvén, C | 1 |
| Hyun, C | 1 |
| Ochoa, PG | 1 |
| Arribas, MT | 1 |
| Mena, JM | 1 |
| Pérez, MG | 1 |
| Ferasin, L | 1 |
| Marcora, S | 1 |
| Mavropoulou, A | 1 |
| Buratti, E | 1 |
| Boer, HH | 1 |
| Nelson, RW | 1 |
| Long, GG | 1 |
| Cosenza, SF | 1 |
| Russo, EA | 1 |
| Raisbeck, MF | 1 |
| Hewitt, WR | 1 |
| McIntyre, WB | 1 |
| Calvert, CA | 1 |
| Thrall, DE | 1 |
| Smal, J | 1 |
| Haapala, O | 1 |
| Marvola, M | 1 |
| Kuusela, S | 1 |
| Happonen, I | 1 |
| Marks, CA | 1 |
| Kessler, M | 1 |
| Häggström, J | 1 |
| Hansson, K | 1 |
| Karlberg, BE | 1 |
| Kvart, C | 1 |
| Madej, A | 1 |
| Olsson, K | 1 |
| Watson, AD | 1 |
| Church, DB | 1 |
| Gavaghan, BJ | 1 |
| Kittleson, MD | 1 |
| Biller, B | 1 |
| Hörauf, A | 1 |
| Kraft, W | 1 |
| Ettinger, SJ | 1 |
| Benitz, AM | 1 |
| Ericsson, GF | 1 |
| Cifelli, S | 1 |
| Jernigan, AD | 1 |
| Longhofer, SL | 1 |
| Trimboli, W | 1 |
| Hanson, PD | 1 |
| Atwell, RB | 1 |
| Thomas, RE | 1 |
| Henness, AM | 1 |
| Ross, JA | 1 |
| De Schepper, J | 1 |
| Hoorens, J | 1 |
| Mattheeuws, D | 1 |
| Van Der Stock, J | 1 |
| Pipers, FS | 1 |
| Carter, KL | 1 |
| Baker, J | 1 |
| Moreau, M | 1 |
| Lussier, B | 1 |
| Pelletier, JP | 1 |
| Martel-Pelletier, J | 1 |
| Bédard, C | 1 |
| Gauvin, D | 1 |
| Troncy, E | 1 |
3 reviews available for furosemide and Canine Diseases
| Article | Year |
|---|---|
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Toward quantification of loop diuretic responsiveness for congestive heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Sodium; Sodium Potassium | 2023 |
Mitral valve prolapse in Cavalier King Charles spaniel: a review and case study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diuretics; Dog Diseases; Dogs; Enalapril; Female; | 2005 |
Evidence for or against clinical efficacy of preload reducers.
Topics: Animals; Cat Diseases; Cats; Dog Diseases; Dogs; Furosemide; Heart Diseases; Humans; Myocardial Cont | 1991 |
7 trials available for furosemide and Canine Diseases
| Article | Year |
|---|---|
Efficacy of oral torasemide in dogs with degenerative mitral valve disease and new onset congestive heart failure: The CARPODIEM study.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Male; Mitral Valve; Sulfonamides; | 2020 |
Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial.
Topics: Animals; Dog Diseases; Dogs; Furosemide; Heart Failure; Mitral Valve; Prospective Studies; Pyridazin | 2020 |
Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease.
Topics: Animals; Cross-Over Studies; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Mitral Valve | 2012 |
Effect of thyroid hormone supplementation on survival of euthyroid dogs with congestive heart failure due to systolic myocardial dysfunction: a double-blind, placebo-controlled trial.
Topics: Animals; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Cardiotonic Agents; Digoxin; Diuretics; Do | 2003 |
[Treatment of mitral valve insufficiency in dogs with the ACE inhibitor enalapril. A clinical progress study].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diuretics; Dog Diseases; Dogs; Drug Therapy, Comb | 1998 |
Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomyopathy, Dilated; Cardiotonic Agents; Deat | 1998 |
A medicinal herb-based natural health product improves the condition of a canine natural osteoarthritis model: a randomized placebo-controlled trial.
Topics: Analysis of Variance; Ananas; Animals; Boswellia; Curcuma; Dog Diseases; Dogs; Harpagophytum; Locomo | 2014 |
53 other studies available for furosemide and Canine Diseases
| Article | Year |
|---|---|
Database development and survival analysis in a clinical and historical cohort of dogs affected by myxomatous mitral valve disease treated or not with pimobendan using causal inference techniques.
Topics: Animals; Dog Diseases; Dogs; Furosemide; Humans; Mitral Valve; Pyridazines; Retrospective Studies; S | 2022 |
Incidence of Sterile Hemorrhagic Cystitis in Dogs Treated with Cyclophosphamide and Low-Dose Furosemide.
Topics: Animals; Antineoplastic Agents, Alkylating; Cyclophosphamide; Cystitis; Dog Diseases; Dogs; Furosemi | 2022 |
Effect of sampling time on urinary electrolytes following oral furosemide administration in dogs with myxomatous mitral valve disease.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Electrolytes; Furosemide; Heart Valve Diseases; Humans; Mitr | 2022 |
Retrospective evaluation of risk factors for development of kidney injury after parenteral furosemide treatment of left-sided congestive heart failure in dogs.
Topics: Acute Kidney Injury; Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Kidney; Retr | 2022 |
Resolution of congestive heart failure and reverse remodeling in two Chihuahuas with flail mitral valve leaflets.
Topics: Animals; Dog Diseases; Dogs; Furosemide; Heart Failure; Heart Valve Diseases; Male; Mitral Valve; Mi | 2023 |
Plasma N-terminal pro-atrial natriuretic peptide concentrations are affected by dehydration in healthy dogs.
Topics: Animals; Atrial Natriuretic Factor; Dehydration; Dog Diseases; Dogs; Echocardiography; Furosemide; P | 2023 |
Dermatologic adverse effect of subcutaneous furosemide administration in a cat.
Topics: Animals; Cat Diseases; Cats; Dog Diseases; Dogs; Edema; Furosemide; Heart Failure; Humans | 2023 |
Impact of a combination of pimobendan, furosemide, and enalapril on heart rate variability in naturally occurring, symptomatic, myxomatous mitral valve degeneration dogs.
Topics: Animals; Cardiotonic Agents; Diuretics; Dog Diseases; Dogs; Enalapril; Furosemide; Heart Rate; Mitra | 2023 |
Prediction and measurement of diuretic responsiveness after oral administration of furosemide to healthy dogs and dogs with congestive heart failure.
Topics: Administration, Oral; Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Humans; Pro | 2020 |
Factors affecting the urinary aldosterone-to-creatinine ratio in healthy dogs and dogs with naturally occurring myxomatous mitral valve disease.
Topics: Aldosterone; Animals; Creatinine; Dog Diseases; Dogs; Female; Furosemide; Heart Valve Diseases; Male | 2021 |
Multiple retrospective analysis of survival and evaluation of cardiac death predictors in a population of dogs affected by degenerative mitral valve disease in ACVIM class C treated with different therapeutic protocols.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cohort Studies; Death; Dog Diseases; Dogs; Female | 2021 |
Clinical relevance of serum electrolytes in dogs and cats with acute heart failure: A retrospective study.
Topics: Animals; Cat Diseases; Cats; Diuretics; Dog Diseases; Dogs; Electrolytes; Furosemide; Heart Failure; | 2021 |
Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Creatinine; Dog Diseases; Dogs; Fema | 2017 |
Clinical findings and survival time in dogs with advanced heart failure.
Topics: Animals; Cardiotonic Agents; Dog Diseases; Dogs; Female; Furosemide; Heart Failure; Male; Mitral Val | 2018 |
Constant rate infusion vs. intermittent bolus administration of IV furosemide in 100 pets with acute left-sided congestive heart failure: A retrospective study.
Topics: Animals; Cat Diseases; Cats; Diuretics; Dog Diseases; Dogs; Female; Furosemide; Heart Failure; Infus | 2018 |
Cardiorenal and endocrine effects of synthetic canine BNP1-32 in dogs with compensated congestive heart failure caused by myxomatous mitral valve disease.
Topics: Aldosterone; Animals; Cross-Over Studies; Dog Diseases; Dogs; Furosemide; Heart Failure; Heart Valve | 2019 |
Postmortem evaluation of renal tubular vacuolization in critically ill dogs.
Topics: Acute Kidney Injury; Animals; Autopsy; Creatinine; Critical Care; Critical Illness; Diuretics; Dog D | 2019 |
Incidence of sterile hemorrhagic cystitis in dogs receiving cyclophosphamide orally for three days without concurrent furosemide as part of a chemotherapeutic treatment for lymphoma: 57 cases (2007-2012).
Topics: Animals; Antineoplastic Agents, Alkylating; Cyclophosphamide; Cystitis; Diuretics; Dog Diseases; Dog | 2013 |
Mesna and furosemide for prevention of cyclophosphamide-induced sterile haemorrhagic cystitis in dogs--a retrospective study.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cystitis; Diuretics; Dog | 2014 |
Furosemide for prevention of cyclophosphamide-associated sterile haemorrhagic cystitis in dogs receiving metronomic low-dose oral cyclophosphamide.
Topics: Administration, Metronomic; Animals; Antineoplastic Agents, Alkylating; Cyclophosphamide; Cystitis; | 2017 |
Acute necrotising pulmonary vasculitis and pulmonary hypertension in a juvenile dog.
Topics: Acute Disease; Animals; Anti-Anxiety Agents; Dog Diseases; Dogs; Fatal Outcome; Female; Furosemide; | 2008 |
Transient tricuspid valve regurgitation following surgical treatment of cor triatriatum dexter in a dog.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Cor Triatriatum; Diuretics; Dog Dis | 2009 |
Syringomyelia in three small breed dogs secondary to Chiari-like malformation: clinical and diagnostic findings.
Topics: Animals; Anti-Inflammatory Agents; Arnold-Chiari Malformation; Body Size; Diuretics; Dog Diseases; D | 2009 |
Evaluation of acute congestive heart failure in dogs and cats: 145 cases (2007-2008).
Topics: Acute Disease; Animals; Cat Diseases; Cats; Diuretics; Dog Diseases; Dogs; Female; Furosemide; Heart | 2010 |
Canine dilated cardiomyopathy: a retrospective study of prognostic findings in 367 clinical cases.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Breeding; Cardiomyopathy, Dilated; Cardiotonic Ag | 2010 |
Use of the loop diuretic torsemide in three dogs with advanced heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Euthanasia, Animal; Fatal Outcome; Female; Furosemide; Heart | 2011 |
[Unauthorized medicine leads to an authorized complained].
Topics: Animals; Clinical Competence; Diuretics; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Furos | 2011 |
[Chocolate intoxication in a dog].
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Blood Gas Analysis; Cacao; Central Venous Pressure; | 2011 |
Survival and echocardiographic data in dogs with congestive heart failure caused by mitral valve disease and treated by multiple drugs: a retrospective study of 21 cases.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Cardiotonic Agents; Death, Sudden, | 2011 |
Lowered N-terminal pro-B-type natriuretic peptide levels in response to treatment predict survival in dogs with symptomatic mitral valve disease.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Female; Furosemide; Heart Failure; Male; Mitral Valve Insuff | 2012 |
Transthoracic echocardiographically-guided interventional cardiac procedures in the dog.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Balloon Valvuloplasty; Benzazepines; Cardiotonic | 2012 |
Risk factors for sterile hemorrhagic cystitis in dogs with lymphoma receiving cyclophosphamide with or without concurrent administration of furosemide: 216 cases (1990-1996).
Topics: Animals; Antineoplastic Agents, Alkylating; Cyclophosphamide; Cystitis; Diuretics; Dog Diseases; Dog | 2003 |
Cutaneous adverse reaction to furosemide treatment: new clinical findings.
Topics: Alopecia; Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Male; Pruritus | 2006 |
A pilot study to assess the feasibility of a submaximal exercise test to measure individual response to cardiac medication in dogs with acquired heart failure.
Topics: Animals; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Cardiotonic Agents; Dog Disease | 2007 |
Aortic endocarditis associated with a perforated septal membranous aneurysm in a boxer dog.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Aorta; Cefazolin; Dog Diseases; Dogs; Electrocardiograp | 2007 |
Colchicine therapy for hepatic fibrosis in a dog.
Topics: Animals; Biopsy; Colchicine; Dog Diseases; Dogs; Female; Furosemide; Liver; Liver Cirrhosis | 1984 |
Furosemide and diabetes mellitus.
Topics: Animals; Diabetes Mellitus; Dog Diseases; Dogs; Furosemide | 1984 |
Iatrogenic metabolic alkalosis with respiratory alkalosis in a dog with patent ductus arteriosus.
Topics: Alkalosis; Alkalosis, Respiratory; Animals; Dog Diseases; Dogs; Ductus Arteriosus, Patent; Female; F | 1983 |
Fatal nephrotoxicosis associated with furosemide and gentamicin therapy in a dog.
Topics: Animals; Bacterial Infections; Dog Diseases; Dogs; Drug Therapy, Combination; Furosemide; Gentamicin | 1983 |
Treatment of canine heartworm disease coexisting with right-side heart failure.
Topics: Animals; Aspirin; Digoxin; Dirofilariasis; Dog Diseases; Dogs; Furosemide; Heart Failure; Rest | 1982 |
Prolonged-release hard gelatin capsules of furosemide for the treatment of dogs.
Topics: Animals; Anticholesteremic Agents; Biological Availability; Capsules; Carboxymethylcellulose Sodium; | 1995 |
Hypertrophic cardiomyopathy in a dog.
Topics: Animals; Cardiomyopathy, Hypertrophic; Diltiazem; Dog Diseases; Dogs; Drug Therapy, Combination; Ech | 1993 |
[Clinical case. Cocker spaniel, female, 12 years old].
Topics: Animals; Anus Neoplasms; Combined Modality Therapy; Diagnosis, Differential; Dog Diseases; Dogs; Fem | 1995 |
Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Dog Dis | 1996 |
Preferences of veterinarians for drugs to treat heart disease in dogs and cats.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Australia; Cardiotonic Agents; Cardiovascular | 1995 |
Dilated cardiomyopathy in an American cocker spaniel with taurine deficiency.
Topics: Animals; Antihypertensive Agents; Breeding; Cardiomyopathy, Dilated; Cardiotonic Agents; Digoxin; Di | 1997 |
The use of alpha blockade in the treatment of congestive heart failure associated with dirofilariasis and mitral valvular incompetence.
Topics: Animals; Digoxin; Dirofilariasis; Dog Diseases; Dogs; Female; Furosemide; Heart Failure; Male; Mitra | 1979 |
A case of canine heartworm disease (Dirofilaria immitis) in the UK.
Topics: Animals; Blood; Dirofilaria immitis; Dirofilariasis; Dog Diseases; Dogs; Electrocardiography; Fluore | 1985 |
Treatment of cyclophosphamide-induced cystitis.
Topics: Animals; Cat Diseases; Cats; Cyclophosphamide; Cystitis; Dog Diseases; Dogs; Female; Furosemide; Mal | 1985 |
Tremor and ataxia in a West Highland white terrier.
Topics: Animals; Ataxia; Diazepam; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Furosemide; Nystag | 1985 |
Gluomerulonephritis and the nephrotic syndrome in a dog.
Topics: Animals; Blood Proteins; Blood Urea Nitrogen; Cholesterol; Creatinine; Dog Diseases; Dogs; Furosemid | 1974 |
Preferences of veterinarians for drugs used to treat heart failure in dogs.
Topics: Animals; Diet, Sodium-Restricted; Digitoxin; Digoxin; Dog Diseases; Dogs; Furosemide; Heart Failure; | 1972 |
Furosemide in small animal practice.
Topics: Animals; Cat Diseases; Cats; Dog Diseases; Dogs; Edema; Furosemide | 1967 |